|
88
|
286
|
3zbxA |
X-ray structure of c-met kinase in complex with inhibitor 6-((6-(4- fluorophenyl)-(1,2,4)triazolo(4,3-b)(1,2,4)triazin-3-yl)methyl) quinoline. |
|
89
|
309
|
3zduA |
Crystal structure of the human cdkl3 kinase domain |
|
85
|
273
|
3we8A |
Pim-1 kinase in complex with ruthenium-based inhibitor |
|
74
|
275
|
3zhpC |
Human mst3 (stk24) in complex with mo25beta |
|
99
|
349
|
3zdiA |
Glycogen synthase kinase 3 beta complexed with axin peptide and inhibitor 7d |
|
94
|
318
|
3w33A |
Egfr kinase domain complexed with compound 19b |
|
78
|
263
|
3w10A |
Aurora kinase a complexed to pyrazole aminoquinoline i |
|
70
|
280
|
3w1fA |
Crystal structure of human mps1 catalytic domain in complex with 5-(5-ethoxy-6-(1-methyl-1h-pyrazol-4-yl)-1h-indazol-3-yl)-2-methylbenzenesulfonamide |
|
99
|
317
|
3w32A |
Egfr kinase domain complexed with compound 20a |
|
92
|
320
|
3w2rA |
Egfr kinase domain t790m/l858r mutant with compound 4 |
|
90
|
322
|
3vvhA |
X-ray structure of the human mitogen-activated protein kinase kinase 1 (mek1) in complex with an inhibitor and mgatp |
|
110
|
358
|
3vuiA |
Crystal structure of a cysteine-deficient mutant m2 in map kinase jnk1 |
|
83
|
269
|
3vw6A |
Crystal structure of human apoptosis signal-regulating kinase 1 (ask1) with imidazopyridine inhibitor |
|
92
|
319
|
3w2sA |
Egfr kinase domain with compound4 |
|
97
|
321
|
3w2qA |
Egfr kinase domain t790m/l858r mutant with hki-272 |
|
52
|
261
|
3w2cA |
Structure of aurora kinase a complexed to benzoimidazole-indazole inhibitor xv |
|
117
|
447
|
3vs6A |
Crystal structure of hck complexed with a pyrazolo-pyrimidine inhibitor tert-butyl {4-[4-amino-1-(propan-2-yl)-1h-pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl}carbamate |
|
98
|
361
|
3vumA |
Crystal structure of a cysteine-deficient mutant m7 in map kinase jnk1 |
|
99
|
322
|
3w2pA |
Egfr kinase domain t790m/l858r mutant with compound 2 |
|
94
|
328
|
3vw8A |
Crystal structure of human c-met kinase domain with its inhibitor |
|
187
|
540
|
3vwaA |
Crystal structure of cex1p |
|
95
|
321
|
3w2oA |
Egfr kinase domain t790m/l858r mutant with tak-285 |
|
71
|
263
|
3w16A |
Structure of aurora kinase a complexed to pyrazole-aminoquinoline inhibitor iii |
|
86
|
347
|
3w55A |
The structure of erk2 in complex with fr148083 |
|
67
|
263
|
3w18A |
Structure of aurora kinase a complexed to benzoimidazole-indazole inhibitor xiii |
|
71
|
291
|
3vn9A |
Rifined crystal structure of non-phosphorylated map2k6 in a putative auto-inhibition state |
|
105
|
307
|
3vo3A |
Crystal structure of the kinase domain of human vegfr2 with imidazo[1,2-b]pyridazine derivative |
|
116
|
447
|
3vs2A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
84
|
292
|
3v5qA |
Discovery of a selective trk inhibitor with efficacy in rodent cancer tumor models |
|
113
|
347
|
3vqhA |
Bromine sad partially resolves multiple binding modes for pka inhibitor h-89 |
|
102
|
307
|
3vntA |
Crystal structure of the kinase domain of human vegfr2 with a [1,3]thiazolo[5,4-b]pyridine derivative |
|
104
|
359
|
3vugA |
Crystal structure of a cysteine-deficient mutant m2 in map kinase jnk1 |
|
38
|
247
|
3vutA |
Crystal structures of non-phosphorylated map2k4 |
|
90
|
322
|
3vjnA |
Crystal structure of the mutated egfr kinase domain (g719s/t790m) in complex with amppnp. |
|
116
|
447
|
3vs5A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-(1-methylpiperidin-4-yl)-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
110
|
447
|
3vs4A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2h-pyran-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
122
|
447
|
3vryA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 4-amino-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane |
|
108
|
358
|
3vuhA |
Crystal structure of a cysteine-deficient mutant m3 in map kinase jnk1 |
|
95
|
358
|
3vulA |
Crystal structure of a cysteine-deficient mutant m1 in map kinase jnk1 |
|
123
|
447
|
3vs3A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
90
|
323
|
3vjoA |
Crystal structure of the wild-type egfr kinase domain in complex with amppnp. |
|
112
|
447
|
3vs1A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea |
|
106
|
447
|
3vs7A |
Crystal structure of hck complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1h-pyrrolo[2,3-b]pyridin-5-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine |
|
109
|
447
|
3vs0A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor n-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]benzamide |
|
117
|
447
|
3vrzA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea |
|
71
|
280
|
3vquA |
Crystal structure of human mps1 catalytic domain in complex with 4-[(4-amino-5-cyano-6-ethoxypyridin-2- yl)amino]benzamide |
|
104
|
358
|
3vukA |
Crystal structure of a cysteine-deficient mutant m5 in map kinase jnk1 |
|
94
|
358
|
3vudA |
Crystal structure of a cysteine-deficient mutant m1 in map kinase jnk1 |
|
75
|
262
|
3v5lA |
Crystal structure of interleukin-2 inducible t-cell kinase itk catalytic domain with thienopyrazolylindole inhibitor 542 |
|
81
|
322
|
3v04A |
Discovery of novel allosteric mek inhibitors possessing classical and non-classical bidentate ser212 interactions. |
